← All trials
NCT05997238
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2023
- Primary completion
- Feb 12, 2024
- Completion date
- May 1, 2024
- First posted
- Aug 18, 2023
- Last posted
- Jun 13, 2024
- Enrollment
- 120
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Peking UniversityLead sponsor
- GMP BIO Co., LTD.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.